NeuroOne Medical Technologies Corporation (NMTC) scores 50 out of 100 on boothcheck's 11-model valuation framework. Verdict: Poor The estimated fair value is 0.22, representing a 70% premium to fair value. Quantitative score: 44/100. Qualitative score: 90/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.